drugset / Trial / NCT05641558
Evaluation of 611 in Chinese Adult Patients With Moderate-to-Severe Atopic Dermatitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective of the study was to evaluate the safety and tolerability of 611 in chinese adults with moderate to severe atopic dermatitis.
Timeline
- Start
- 2021-10-18
- Primary completion
- 2022-10-21
- Completion
- 2022-10-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 611 | Unknown | 150 mg | Subcutaneous |
| Subject | 611 | Unknown | 300 mg | Subcutaneous |